Flagship Founder and CEO Noubar Afeyan was joined by Aviv Regev, Executive Vice President at Genentech Research and Early Development (gRED) for a fascinating discussion on the intersection of AI and biology, the future of R&D, and the leaps in store for biomedicine. More from Flagship @ JPM2023 here.
More from:
Human Health
Logica Partnership Panel: Pioneering Medicines, Charles River Labs, and Valo Health
Pioneering Women in Biotech
Rare Disease Day is Every Day For Many Families, But it Doesn’t Have to Be
Flagship Celebrates International Day of Women and Girls in Science
Artificial Intelligence and the Future of Healthcare and Biotech
